stockportfolio.pro
Stocks / ASMB vs WEAV
ASMB vs WEAV
Assembly Biosciences, Inc. and Weave Communications, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Assembly Biosciences, Inc. (ASMB) | Weave Communications, Inc. (WEAV) | |
|---|---|---|
| Market cap | $0.4B | $0.4B |
| Revenue (latest FY) | $72.30M | $239.02M |
| Net income (latest FY) | $-6.12M | $-28.05M |
| Revenue growth (5y CAGR) | -1.8% | 24.5% |
| Net margin | -8.5% | -11.7% |
| Return on equity | -3.0% | -34.1% |
| P/E ratio | 275.2 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ASMB — free Open WEAV — freeFrequently asked questions
Which is bigger, ASMB or WEAV?
Assembly Biosciences, Inc. is larger by market capitalization — $0.4B versus $0.4B.
Which grows faster, ASMB or WEAV?
Over the last five fiscal years, Weave Communications, Inc. grew revenue faster — 24.5%/yr versus -1.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.